BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26118635)

  • 1. Fractional anisotropy in the substantia nigra in Parkinson's disease: a complex picture.
    Lenfeldt N; Larsson A; Nyberg L; Birgander R; Forsgren L
    Eur J Neurol; 2015 Oct; 22(10):1408-14. PubMed ID: 26118635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits.
    Schuff N; Wu IW; Buckley S; Foster ED; Coffey CS; Gitelman DR; Mendick S; Seibyl J; Simuni T; Zhang Y; Jankovic J; Hunter C; Tanner CM; Rees L; Factor S; Berg D; Wurster I; Gauss K; Sprenger F; Seppi K; Poewe W; Mollenhauer B; Knake S; Mari Z; McCoy A; Ranola M; Marek K
    Mov Disord; 2015 Dec; 30(14):1885-92. PubMed ID: 26260437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetrical diffusion tensor imaging indices of the rostral substantia nigra in Parkinson's disease.
    Prakash BD; Sitoh YY; Tan LC; Au WL
    Parkinsonism Relat Disord; 2012 Nov; 18(9):1029-33. PubMed ID: 22705126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microstructural changes in the substantia nigra of asymptomatic agricultural workers.
    Du G; Lewis MM; Sterling NW; Kong L; Chen H; Mailman RB; Huang X
    Neurotoxicol Teratol; 2014; 41():60-4. PubMed ID: 24334261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.
    Du G; Lewis MM; Styner M; Shaffer ML; Sen S; Yang QX; Huang X
    Mov Disord; 2011 Aug; 26(9):1627-32. PubMed ID: 21618607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free-water imaging in Parkinson's disease and atypical parkinsonism.
    Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
    Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study.
    Zhang Y; Wu IW; Tosun D; Foster E; Schuff N;
    PLoS One; 2016; 11(10):e0165540. PubMed ID: 27798653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI diffusion in Parkinson's disease: using the technique's inherent directional information to study the olfactory bulb and substantia nigra.
    Skorpil M; Söderlund V; Sundin A; Svenningsson P
    J Parkinsons Dis; 2012; 2(2):171-80. PubMed ID: 23939442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractional Anisotropy and Mean Diffusion as Measures of Dopaminergic Function in Parkinson's Disease: Challenging Results.
    Lenfeldt N; Eriksson J; Åström B; Forsgren L; Mo SJ
    J Parkinsons Dis; 2017; 7(1):129-142. PubMed ID: 28106567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substantia nigra in Parkinson's disease: a multimodal MRI comparison between early and advanced stages of the disease.
    Aquino D; Contarino V; Albanese A; Minati L; Farina L; Grisoli M; Romita L; Elia AE; Bruzzone MG; Chiapparini L
    Neurol Sci; 2014 May; 35(5):753-8. PubMed ID: 24337946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.
    Schwarz ST; Abaei M; Gontu V; Morgan PS; Bajaj N; Auer DP
    Neuroimage Clin; 2013; 3():481-8. PubMed ID: 24273730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case control study of diffusion tensor imaging in Parkinson's disease.
    Chan LL; Rumpel H; Yap K; Lee E; Loo HV; Ho GL; Fook-Chong S; Yuen Y; Tan EK
    J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1383-6. PubMed ID: 17615165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parkinson's disease: diffusion kurtosis imaging and the correlation with clinical manifestations].
    Sun YQ; Zhang Q; Jiang Z; Zhang CY; Zhang JW; Chen H; Shen JK
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(45):3534-3537. PubMed ID: 29275590
    [No Abstract]   [Full Text] [Related]  

  • 16. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease.
    Vaillancourt DE; Spraker MB; Prodoehl J; Abraham I; Corcos DM; Zhou XJ; Comella CL; Little DM
    Neurology; 2009 Apr; 72(16):1378-84. PubMed ID: 19129507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Resonance Imaging Biomarkers to Assess Substantia Nigra Damage in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.
    Pyatigorskaya N; Gaurav R; Arnaldi D; Leu-Semenescu S; Yahia-Cherif L; Valabregue R; Vidailhet M; Arnulf I; Lehéricy S
    Sleep; 2017 Nov; 40(11):. PubMed ID: 28958075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigra.
    Joshi N; Rolheiser TM; Fisk JD; McKelvey JR; Schoffer K; Phillips G; Armstrong M; Khan MN; Leslie RA; Rusak B; Robertson HA; Good KP
    J Neurol; 2017 Jul; 264(7):1497-1505. PubMed ID: 28653210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution diffusion tensor-imaging indicates asymmetric microstructural disorganization within substantia nigra in early Parkinson's disease.
    Knossalla F; Kohl Z; Winkler J; Schwab S; Schenk T; Engelhorn T; Doerfler A; Gölitz P
    J Clin Neurosci; 2018 Apr; 50():199-202. PubMed ID: 29366621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantia nigra fractional anisotropy is not a diagnostic biomarker of Parkinson's disease: A diagnostic performance study and meta-analysis.
    Hirata FCC; Sato JR; Vieira G; Lucato LT; Leite CC; Bor-Seng-Shu E; Pastorello BF; Otaduy MCG; Chaim KT; Campanholo KR; Novaes NP; Melo LM; Gonçalves MR; do Nascimento FBP; Teixeira MJ; Barbosa ER; Amaro E; Cardoso EF
    Eur Radiol; 2017 Jun; 27(6):2640-2648. PubMed ID: 27709279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.